Lucera Erick Insider Trades

Insider Trading History

Track insider trading activity for Lucera Erick. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $2.89M 121,563 shares
Last Trade
Jun 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.1k 2,362 shares
$20.37
$23.78
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $2.95M 123,925 shares
Last Trade
May 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.6k 1,448 shares
$18.36
$23.78
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $2.98M 125,373 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$107k 5,727 shares
$18.64
$23.78
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $3.12M 131,100 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.72M 170,000 shares
$16.00
$23.78
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $2.12k 150,000 shares
Last Trade
Dec 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.71k 150,000 shares
$0.02
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $540k 150,000 shares
Last Trade
Dec 16, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$599k 150,000 shares
$3.99
$3.60
Beyond Air
Beyond Air XAIR
Director
Holding Value $21.6k 3,750 shares
Last Trade
Nov 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.9k 11,750 shares
$1.95
$5.77
Beyond Air
Beyond Air XAIR
Director
Holding Value $0 0 shares
Last Trade
Nov 04, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.3k 5,000 shares
$1.86
$5.77
Dyne Therapeutics
Dyne Therapeutics DYN
Chief Financial Officer
Holding Value $5.1M 214,500 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.24M 214,500 shares
$10.46
$23.78
Beyond Air
Beyond Air XAIR
Director
Holding Value $433k 75,000 shares
Last Trade
Mar 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$442k 75,000 shares
$5.89
$5.77
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $869k 275,100 shares
Last Trade
Mar 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$594k 345,100 shares
$1.72
$3.16
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $356k 112,720 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.03k 4,109 shares
$1.71
$3.16
Beyond Air
Beyond Air XAIR
Director
Holding Value $260k 45,000 shares
Last Trade
Nov 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73M 160,000 shares
$10.80
$5.77
Beyond Air
Beyond Air XAIR
Director
Holding Value $0 0 shares
Last Trade
Nov 22, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.27M 210,000 shares
$10.80
$5.77
Beyond Air
Beyond Air XAIR
Director
Holding Value $252k 43,608 shares
Last Trade
Aug 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$314k 39,266 shares
$8.00
$5.77
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Director
Holding Value $282 20,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$766 20,000 shares
$0.04
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Director
Holding Value $72k 20,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$58k 20,000 shares
$2.90
$3.60
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $369k 116,829 shares
Last Trade
May 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$125k 22,337 shares
$5.61
$3.16
Beyond Air
Beyond Air XAIR
Director
Holding Value $260k 45,000 shares
Last Trade
Mar 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 45,000 shares
$30.80
$5.77
Editas Medicine
Editas Medicine EDIT
Evp, CHIEF FINANCIAL OFFICER
Holding Value $440k 139,166 shares
Last Trade
Mar 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 106,000 shares
$10.53
$3.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up